1. Introduction {#sec0005}
===============

Synchronous rectosigmoid mucinous adenocarcinoma seeding an anal fistula is a very rare condition. Diagnosis is difficult especially when primary tumor remains unknown and the chronic lesion of anal fistula seems to be a benign condition. The management of these cases remain controversial. We present a rare case of chronic anal fistula with the presence of a reccurent perianal abscess with synchronous rectosigmoid mucinous adenocarcinoma, treated with laparoscopic extraelevator abdominoperineal resection. A persistent anal fistula with recurrent inflammation is known to lead to primary cancer, and such cancer develops in 0,1% of all anal fistulae [@bib0005], [@bib0010]. This case highlights the importance of further investigation and the need of biopsy in anal fistulae. Our case has been reported in line with the SCARE criteria [@bib0015], a 14-item checklist that was formulated to help improve the reporting quality of case reports.

2. Case presentation {#sec0010}
====================

A Caucasian Greek 79 years old male presented in our general hospital for investigation of an anal fistula with a recurrent perianal abscess that was treated as a benign condition. ([Fig. 1](#fig0005){ref-type="fig"}) Clinical examination revealed the presence of a longstanding perianal fistula which appeared to be transsphincteric. The patient underwent pelvis Magnetic Resonance Imaging ([Fig. 2](#fig0010){ref-type="fig"}) and colonoscopy. Biopsy was taken the histopathology examination revealed a well differentiated mucinous adenocarcinoma in two synchronous tumors with CK20 markers positive and CK7 markers negative.The possibility of primary cancer in the rectosigmoid with metastatic seeding in the perianal fistula could not be excluded.Fig. 1Peri-anal fistula before surgery.Fig. 1Fig. 2Fistula presenting in pelvic MRI.Fig. 2

The patient underwent laparoscopic abdominoperineal resection with complete excision of both lesions ([Fig. 3](#fig0015){ref-type="fig"}) and the pelvic floor was strengthened by a biological mesh([Fig. 4](#fig0020){ref-type="fig"}) The histological examination of the resection margin confirmed the diagnosis of well diffentieted mucinous adenocarcinoma with 34 lymph nodes in the pericolonic fat with maximum diameter of 0,2--0,7 cm, all negative for cancerous infiltration (T3N0M0). The resection margin was classified as R0. The postoperative course of the patient was normal. He was discharged on the 6th postoperative day.Fig. 3Surgical specimen.Fig. 3Fig. 4Pelvis floor construction with biological mesh.Fig. 4

3. Discussion {#sec0015}
=============

Synchronous adenocarcinoma of the rectosigmoid, seeding in an anal fistula, presenting as a recurrent perianal abscess is extremely rare. Symptoms in these patients appear due to their perianal disease. That's why the coexisting carcinoma is missed. There is an important observation about sex prevalence, all cases reported were male except only one female. In all cases of fistula and perianal abscess it is very important that histological examination is performed [@bib0020], [@bib0025], [@bib0030].

For the first time in 1907 Charles Ryall reported implantation metastasis of solid cancers and described this phenomenon as cancer infection [@bib0025], [@bib0035], [@bib0040].

The first case of cancer implantation to a perianal fistula was reported in 1954 by Guiss and al. Since then, more cases have been reported and metastasis of colorectal cancer into a perianal fistula has become accepted even if the management remains a matter of controversy [@bib0035]. In our case, the symptoms of our patient was attributed to his perianal disease and the primary carcinoma was missed. It is important that clinicians who manage patients with anal fistulae and recurrent perianal abscesses to referee them for further colonic investigation (colonoscopy and biopsies) in order to exclude the possibility of primary carcinoma.

Rosser in 1931 first described the following basic criteria which determine if a fistula has undergone malignant transformation. These include persistence of anal fistula for more than ten years, presence of mucous secretion, no evidence of tumor in the rectal or anal canal mucosa and internal opening of the fistula negative of malignancy [@bib0045], [@bib0050].

Sumikoski, Skir and Mclntyre et al. and Rundle [@bib0050], [@bib0055], [@bib0060] established the diagnostic criteria for primary cancer in anal fistula:1)recurring inflammation of the fistula for at least ten years2)Secretion of mucous3)pain and induration at the fistula4)no primary cancer at the rectum and anus and5)presence of fistula orifice in the anal canal or presence of anal crypt.

There are 24 reported cases of colonic adenocarcinima seeding into anal fistula [@bib0020], [@bib0065], [@bib0070], [@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100], [@bib0105], [@bib0110], [@bib0115], [@bib0120], [@bib0125] and the vast majority of cases regard male patients [@bib0025]. Marker as CK20 and CK7 can be useful in distinguishing the original from the metastatic carcinoma as the literature reports [@bib0020], [@bib0025].

Remalingam et. Al. have described that anal glands were strongly immunoreactive for CK20 and negative for CK7. In this case both lesions are negative for CK7 and positive for CK20 [@bib0130].

The histogenesis of a carcinoma in anal fistula remains controversial. There are many theories about this. Dukes and Calvin suggested that such tumors arise via an unusual duplication of the mucosa [@bib0135]. Zimberg and Kay showed that even for tumors arising from anal fistula the most common site is the anal gland [@bib0140]. Also Nielsen and Koch report the same theory [@bib0145] Taniguchi et al. reported that these tumors originate from the rectal mucosal cells that migrate into the anal canal [@bib0150]. However the histogenesis of these carcinomas remains unclear.

The management of these cases remain controversial. There are no specific recommendations. In some cases authors suggest abdominoperineal resection in others local resection is proposed. The 5 years survival rate is less than 20% in most series [@bib0155].

In our case the patient underwent surgery. Laparoscopic extralevator abdominoperineal excision with both lesions resection (adenocarcinoma of rectosigmoid and adenocarcinoma of the anal fistula) was performed. The pelvic floor was strengthened by a biological mesh.

4. Conclusions {#sec0020}
==============

The diagnosis of synchronous mucinous adenocarcinoma of the rectosigmoid and anal fistula, a very rare condition is not always easy to be established, and remains difficult when the colonic tumor is unknown and the chronic lesion of anal fistula seems to be a benign condition. Furthermore, the treatment is still controversial. We reported the case of a patient who was treated with extralevator abdominoperineal resection. There is no recurrence after four years of follow up. A better prognosis is expected in the future by using different modalities of treatment. This case highlights the importance of suspicion in recurrence of anal fistula and the importance of biopsy in all anal fistulae.
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